All 34 MEDX (HORIZON KINETICS MEDICAL ETF) Holdings
There are 34 MEDX holdings. Top 10 companies weight: 70.47%.
Total Market Cap: $3.45T
Rank | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (34 stocks) | +10.81% | 27.35 | 20.80 | 0.34 | +9.85% | +19.12% | 0.47 | ||||||||||
1 | LLY | Eli Lilly And Co | 18.46% | $1,146.37 | $1.03T | Drug Manufacturers - General | Healthcare | +29.14% | 48.44 | 33.67 | 0.19 | N/A | N/A | 71 | +10.82% | $1.27K | +38.32% | 0.65 |
2 | ABBV | Abbvie Inc | 8.85% | $253.44 | $432B | Drug Manufacturers - General | Healthcare | -19.65% | 139.08 | 18.02 | 0.40 | N/A | N/A | 74 | +5.18% | $267 | +21.10% | 0.28 |
3 | n/a | Us Bank Mmda Usbgfs 7 | 7.26% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
4 | NVS | Novartis Ag Adr | 6.89% | $149.56 | $289B | Drug Manufacturers - General | Healthcare | +14.96% | 21.60 | 17.42 | 2.32 | N/A | N/A | 62 | +3.34% | $155 | +14.78% | 0.23 |
5 | JNJ | Johnson & Johnson | 5.59% | $248.94 | $595B | Drug Manufacturers - General | Healthcare | +11.59% | 22.09 | 21.74 | 4.95 | N/A | N/A | 70 | +8.44% | $270 | +11.07% | N/A |
6 | ALKS | Alkermes Plc | 5.53% | $51.72 | $8.65B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | 56.04 | 136.99 | 1.96 | N/A | N/A | N/A | N/A | N/A | +16.50% | N/A |
7 | AZN:XLON | Astrazeneca Plc | 4.98% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
8 | IONS | Ionis Pharmaceuticals Inc | 4.53% | $52.95 | $9.08B | Biotechnology | Healthcare | -21.44% | N/A | 90.91 | N/A | N/A | N/A | 79 | +75.54% | $93 | +7.60% | 0.65 |
9 | BMY | Bristol-myers Squibb Co | 4.42% | $60.18 | $120B | Drug Manufacturers - General | Healthcare | +5.08% | 13.82 | 9.59 | 1.54 | N/A | N/A | N/A | N/A | N/A | +1.92% | N/A |
10 | MRK | Merck & Co Inc | 3.96% | $124.40 | $292B | Drug Manufacturers - General | Healthcare | +5.37% | 26.93 | 47.17 | 6.13 | N/A | N/A | 68 | +7.75% | $134 | +13.73% | 0.29 |
11 | AMGN | Amgen Inc | 3.91% | $364.17 | $193B | Drug Manufacturers - General | Healthcare | +3.49% | 24.75 | 16.47 | 0.79 | N/A | N/A | 60 | -2.07% | $357 | +11.73% | 0.46 |
12 | ALNY | Alnylam Pharmaceuticals Inc | 3.42% | $272.67 | $37B | Biotechnology | Healthcare | N/A | 117.96 | 30.49 | 0.52 | N/A | N/A | 74 | +59.47% | $435 | +8.65% | 0.81 |
13 | BIIB | Biogen Inc | 3.09% | $199.95 | $29B | Drug Manufacturers - General | Healthcare | -15.32% | 17.41 | 14.75 | 0.64 | N/A | N/A | 65 | +13.17% | $226 | -9.14% | 0.51 |
14 | PFE | Pfizer Inc | 2.86% | $24.75 | $141B | Drug Manufacturers - General | Healthcare | -6.35% | 11.65 | 8.58 | 0.09 | N/A | N/A | 58 | +16.32% | $29 | -4.84% | 0.38 |
15 | GSK | Gsk Plc Adr | 2.71% | $50.05 | $105B | Drug Manufacturers - General | Healthcare | +4.65% | 12.10 | 21.69 | 0.10 | N/A | N/A | 53 | +16.06% | $58 | +4.57% | 0.23 |
16 | CRSP | Crispr Therapeutics Ag | 2.64% | $46.99 | $4.95B | Biotechnology | Healthcare | +2.10% | N/A | 23.36 | N/A | N/A | N/A | 70 | +83.46% | $86 | -18.22% | 1.44 |
17 | REGN | Regeneron Pharmaceuticals Inc | 2.06% | $672.15 | $69B | Biotechnology | Healthcare | +20.31% | 15.86 | 15.08 | 88.04 | N/A | N/A | 72 | +21.87% | $819 | +3.03% | 0.60 |
18 | BEAM | Beam Therapeutics Inc | 1.51% | $26.33 | $3.17B | Biotechnology | Healthcare | -36.45% | N/A | N/A | N/A | N/A | N/A | 73 | +98.67% | $52 | -23.20% | 1.82 |
19 | GALT | Galectin Therapeutics Inc | 1.14% | $4 | $313M | Biotechnology | Healthcare | -2.50% | N/A | 4.54 | N/A | N/A | N/A | 75 | +175.00% | $11 | +7.24% | 0.59 |
20 | NTLA | Intellia Therapeutics Inc | 1.12% | $10.92 | $1.57B | Biotechnology | Healthcare | +8.10% | N/A | N/A | N/A | N/A | N/A | 62 | +139.65% | $26 | -41.00% | 1.77 |
21 | SDZNY | Sandoz Group Ag Adr | 0.80% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
22 | VNDA | Vanda Pharmaceuticals Inc | 0.73% | $5.32 | $352M | Biotechnology | Healthcare | N/A | N/A | 103.09 | N/A | N/A | N/A | 68 | +165.41% | $14 | -22.64% | 0.64 |
23 | REPL | Replimune Group Inc | 0.73% | $10.51 | $801M | Biotechnology | Healthcare | +16.21% | N/A | N/A | N/A | N/A | N/A | 56 | +1.52% | $11 | -20.66% | 0.74 |
24 | HLN | Haleon Plc Adr | 0.60% | $10.05 | $44B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | 12.02 | 19.12 | 0.26 | N/A | N/A | 75 | +15.98% | $12 | 0.00% | 0.13 |
25 | LTRN | Lantern Pharma Inc Ordinary Shares | 0.55% | $2.95 | $35M | Biotechnology | Healthcare | +5.65% | N/A | N/A | N/A | N/A | N/A | 75 | +577.97% | $20 | -26.56% | 1.89 |
26 | EDIT | Editas Medicine Inc | 0.47% | $2.88 | $349M | Biotechnology | Healthcare | -10.67% | N/A | N/A | N/A | N/A | N/A | 55 | +100.69% | $5.78 | -42.06% | 2.15 |
27 | BCYC | Bicycle Therapeutics Plc Adr | 0.28% | $4.16 | $294M | Biotechnology | Healthcare | +11.06% | N/A | N/A | N/A | N/A | N/A | 72 | +203.37% | $13 | -34.62% | 1.26 |
28 | GEHC | Ge Healthcare Technologies Inc Common Stock | 0.28% | $62.83 | $29B | Medical Devices | Healthcare | N/A | 15.31 | 12.90 | 1.23 | N/A | N/A | 73 | +26.26% | $79 | 0.00% | 1.11 |
29 | VTRS | Viatris Inc | 0.26% | $16.99 | $19B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | N/A | 7.02 | 0.14 | N/A | N/A | 60 | +4.83% | $18 | +8.31% | 0.79 |
30 | ALLO | Allogene Therapeutics Inc | 0.18% | $1.77 | $465M | Biotechnology | Healthcare | -14.18% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -39.94% | N/A |
31 | n/a | Other Assets And Liabilities | 0.10% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
32 | PACB | Pacific Biosciences Of California Inc | 0.09% | $1.36 | $475M | Medical Devices | Healthcare | +5.07% | N/A | N/A | N/A | N/A | N/A | 57 | +80.74% | $2.46 | -46.62% | 1.95 |
33 | DCOY | Decoy Therapeutics Inc | 0.00% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
34 | n/a | Pathos Ai Inc | 0.00% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
MEDX (HORIZON KINETICS MEDICAL ETF) Sector Allocation
HEALTHCARE
73.70%MATERIALS
5.00%INFORMATION TECHNOLOGY
0.00%COMMUNICATION SERVICES
0.00%CONSUMER DISCRETIONARY
0.00%CONSUMER STAPLES
0.00%INDUSTRIALS
0.00%UTILITIES
0.00%ENERGY
0.00%FINANCIALS
0.00%REAL ESTATE
0.00%